This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). It is particularly significant in the development of enantiomerically pure drugs, where the stereochemistry plays a crucial role in the efficacy and safety of the final product. The compound's structure, featuring both a dichloro-fluorophenyl group and a methoxy-phenylacetate moiety, makes it a valuable building block for creating molecules with potential therapeutic applications, such as anti-inflammatory, antiviral, or anticancer agents. Its use in asymmetric synthesis allows for the production of drugs with high enantiomeric purity, which is essential for minimizing side effects and enhancing pharmacological activity.